Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Feb
25
2019
Enforcement Activity by the USDA Food Safety Inspection Service Against Imported Siluriformes (Catfish) for “Failure to Present” Violations Keller and Heckman LLP
Feb
22
2019
Insurance Coverage for Defendants Named in Nationwide Opioid Litigation Barnes & Thornburg LLP
Feb
22
2019
FDA Adds Ten New Substances to its Inventory of Effective FCS Notifications Keller and Heckman LLP
Feb
22
2019
Annual EU Competition Review 2018 McDermott Will & Emery
Feb
22
2019
What are FDA regulations concerning UV coatings? Keller and Heckman LLP
Feb
22
2019
FDA Proposed Rule for OTC Sunscreen Drug Products Addresses Sunscreens Containing Nanomaterials Bergeson & Campbell, P.C.
Feb
21
2019
Device Modernization Series: FDA’s Changes to the 510(k) Program Mintz
Feb
21
2019
CMS Continues to Combat the Opioid Epidemic Mintz
Feb
21
2019
Washington State Requests Input on PFAS Alternatives Assessment Keller and Heckman LLP
Feb
21
2019
Dog Food Makers Face Multiple Class Action Lawsuits Following Vitamin D Recalls Keller and Heckman LLP
Feb
20
2019
Medical Marijuana Rollout in Ohio Dinsmore & Shohl LLP
Feb
20
2019
Independent Laboratory Settles Medical Necessity Allegations Mintz
Feb
20
2019
Tobacco Company Altria has $12.8 Billion Stake in Juul—FDA Concerned Stark & Stark
Feb
20
2019
Are you on the Prop 65 “Bounty Hunter” Radar? Beware, Online Sale of Wine Into California Could Cost You $2500 a Pop! Polsinelli PC
Feb
20
2019
Criticism of FDA’s Produce Safety Rule Implementation Delay Following Romaine Outbreak Report Keller and Heckman LLP
Feb
19
2019
In re Celexa and Lexapro – The First Circuit Weighs in on China Agritech and American Pipe Tolling Pierce Atwood LLP
Feb
19
2019
USDA Proposed Amendments to National List of Allowed and Prohibited Substances Keller and Heckman LLP
Feb
18
2019
Financial Services and the Marijuana Industry: the U.S. House Mulls Regulatory Reform for Financial Institutions and Cannabis-Related Businesses Ballard Spahr LLP
Feb
16
2019
Recent Federal Developments February 15, 2019 EPA /FDA / TSCA / FIFRA /TRI Bergeson & Campbell, P.C.
Feb
15
2019
NC CBD Companies Take Notice: NC Dept. of Agriculture Issues CBD Advisory Ward and Smith, P.A.
Feb
15
2019
McDermottPlus Check-Up: February 15, 2019 McDermott Will & Emery
Feb
15
2019
FDA Publishes Findings from Investigation of Romaine Lettuce E. coli Outbreak Keller and Heckman LLP
Feb
14
2019
Regulatory Developments EC Begins Public Consultation on Evaluation of FCMs Bergeson & Campbell, P.C.
Feb
14
2019
FDA Takes Action on Dietary Supplements Claiming to Treat Alzheimer’s Disease and Other Serious Conditions Keller and Heckman LLP
Feb
14
2019
Remote Prescribing Trends in Telehealth Epstein Becker & Green, P.C.
Feb
14
2019
HIMMS19 Conference – Blockchain Symposium Recap Sheppard, Mullin, Richter & Hampton LLP
Feb
13
2019
CBD “Edibles” Face Opposition from States, FDA Epstein Becker & Green, P.C.
Feb
13
2019
JRC Publishes Overview of Concepts and Terms Used in the EC’s Definition of Nanomaterial Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins